Related Experiment Video
Updated: Mar 29, 2026

03:40
Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
Published on: December 8, 2023
2.0K
Spanning the canyon between stem cell transplantation and palliative care
1University of California, San Diego, Moores Cancer Center, Oncology and Palliative Care, La Jolla, CA; and.
Hematology. American Society of Hematology. Education Program
|December 6, 2015
Summary
Integrating palliative care (PC) with stem cell transplantation (SCT) improves patient outcomes. This approach, starting at diagnosis, enhances quality of life and survival for hematologic malignancy patients.
Area of Science:
- Hematology
- Oncology
- Palliative Care
- Stem Cell Transplantation
Background:
- Stem cell transplantation (SCT) and palliative care (PC) are often viewed as separate components of cancer treatment.
- Hematologic malignancies require complex care, highlighting the need for integrated supportive services.
- Palliative care is increasingly recognized for its benefits in improving quality of life and survival in cancer patients.
Purpose of the Study:
- To explore the integration of palliative care (PC) within stem cell transplantation (SCT) for hematologic malignancies.
- To highlight the shared principles and mutual learning opportunities between SCT and PC.
- To advocate for early integration of PC from the time of diagnosis, based on patient needs.
Main Methods:
- Review of a decade-long experience at a single academic medical center implementing an integrated SCT and PC model.
- Analysis of the conceptualization and role of PC within the SCT continuum of care.
- Discussion of strategies for strengthening collaboration between SCT and PC services.
Main Results:
- The integration of PC into SCT demonstrates shared goals and potential for mutual benefit.
- Early integration of PC, irrespective of prognosis, is feasible and beneficial.
- Collaboration can enhance the overall care experience for patients undergoing SCT.
Conclusions:
- Palliative care should be an integral part of stem cell transplantation from the point of diagnosis.
- The integration of PC and SCT offers significant advantages in patient care, quality of life, and survival.
- Future efforts should focus on strengthening the collaborative relationship between these two specialties.
Related Concept Videos
Bone Marrow Sampling and Transplants
2.4K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.4K
Stem Cell Therapy for Tissue Regeneration
4.9K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.9K
Tissue Transplantation
1.2K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.2K
Regulation of Hematopoietic Stem Cells
4.4K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.4K
Stem Cell Culture
6.5K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.5K
Multipotency of Hematopoietic Stem Cells
4.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.1K

